newsfilter
← Latest News
GlobeNewswire·

Eagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property Portfolio

WOODCLIFF LAKE, N.J., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) ("Eagle" or the "Company") today provided an update on its bendamustine intellectual property portfolio. On January